+

WO1999031230A3 - Nouveau gene appele oligophrenine 1, produit d'expression, et applications diagnostiques et therapeutiques - Google Patents

Nouveau gene appele oligophrenine 1, produit d'expression, et applications diagnostiques et therapeutiques Download PDF

Info

Publication number
WO1999031230A3
WO1999031230A3 PCT/EP1998/008557 EP9808557W WO9931230A3 WO 1999031230 A3 WO1999031230 A3 WO 1999031230A3 EP 9808557 W EP9808557 W EP 9808557W WO 9931230 A3 WO9931230 A3 WO 9931230A3
Authority
WO
WIPO (PCT)
Prior art keywords
oligophrenin
diagnostic
expression product
therapeutic applications
nucleotide
Prior art date
Application number
PCT/EP1998/008557
Other languages
English (en)
Other versions
WO1999031230A2 (fr
Inventor
Jamel Chelly
Pierre Billuart
Axel Kahn
Cherif Beldjord
Original Assignee
Inst Nat Sante Rech Med
Jamel Chelly
Pierre Billuart
Axel Kahn
Cherif Beldjord
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Jamel Chelly, Pierre Billuart, Axel Kahn, Cherif Beldjord filed Critical Inst Nat Sante Rech Med
Priority to EP98966703A priority Critical patent/EP1037993A2/fr
Priority to JP2000539130A priority patent/JP2002508177A/ja
Priority to CA002315268A priority patent/CA2315268A1/fr
Publication of WO1999031230A2 publication Critical patent/WO1999031230A2/fr
Publication of WO1999031230A3 publication Critical patent/WO1999031230A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne l'identification d'un nouveau gène, appelé oligophrénine 1, le produit de son expression, ainsi que les applications diagnostiques et thérapeutiques de ces séquences nucléotidiques et peptidiques.
PCT/EP1998/008557 1997-12-15 1998-12-14 Nouveau gene appele oligophrenine 1, produit d'expression, et applications diagnostiques et therapeutiques WO1999031230A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP98966703A EP1037993A2 (fr) 1997-12-15 1998-12-14 Nouveau gene appele oligophrenine 1, produit d'expression, et applications diagnostiques et therapeutiques
JP2000539130A JP2002508177A (ja) 1997-12-15 1998-12-14 オリゴフレニン１と称される新規の遺伝子、その発現生成物、並びにその診断及び治療的用途
CA002315268A CA2315268A1 (fr) 1997-12-15 1998-12-14 Oligophrenine 1, produit d'expression, et applications diagnotisques et therapeutiques

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97403050.4 1997-12-15
EP97403050 1997-12-15

Publications (2)

Publication Number Publication Date
WO1999031230A2 WO1999031230A2 (fr) 1999-06-24
WO1999031230A3 true WO1999031230A3 (fr) 1999-08-12

Family

ID=8229926

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/008557 WO1999031230A2 (fr) 1997-12-15 1998-12-14 Nouveau gene appele oligophrenine 1, produit d'expression, et applications diagnostiques et therapeutiques

Country Status (4)

Country Link
EP (1) EP1037993A2 (fr)
JP (1) JP2002508177A (fr)
CA (1) CA2315268A1 (fr)
WO (1) WO1999031230A2 (fr)

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BIENVENU, T. ET AL.: "Mapping of the X-breakpoint involved in a balanced X;12 translocation in a female with mild mental retardation.", EUROPEAN JOURNAL OF HUMAN GENETICS, vol. 5, 1997, pages 105 - 109, XP002067476 *
BILLUART, P. ET AL.: "Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation.", NATURE, vol. 392, no. 6679, 30 April 1998 (1998-04-30), pages 923 - 6, XP002104856 *
BILLUART, P. ET AL.: "Oligophrénine-1, une protéine Rho-GAP impliquée dans une forme non spécifique de retard mental lié au chromosome X", MÉDICINE/SCIENCES, vol. 14, no. 5, May 1998 (1998-05-01), pages 679 - 81, XP002104857 *
BILLUERT, P. ET AL.: "L'oligophrénine 1 code pour une protéine rho-GAP impliquée dans un retard mental lié au chromosome X", PATHOLOGIE BIOLOGIE, vol. 46, no. 9, November 1998 (1998-11-01), pages 678, XP002104858 *
DATABASE EMBL - EMHTG 8 November 1996 (1996-11-08), WRAY, P.: "Human DNA sequence *** SEQUENCING IN PROGRESS *** from clone 360E18", XP002067478 *
DATABASE EMBL - EMHUM1 23 August 1997 (1997-08-23), PEARCE, A.: "Human DNA sequence from PAC 63m23 on chromosome Xq13.1-Xq21.1", XP002067479 *
DATABASE EMBL - R45U053 15 April 1998 (1998-04-15), CHELLY, J.: "Homo sapiens mRNA for oligophrenin 1", XP002067477 *

Also Published As

Publication number Publication date
EP1037993A2 (fr) 2000-09-27
JP2002508177A (ja) 2002-03-19
CA2315268A1 (fr) 1999-06-24
WO1999031230A2 (fr) 1999-06-24

Similar Documents

Publication Publication Date Title
CA2200371A1 (fr) Gene humain npik
AU5914196A (en) Hydrophobins from edible fungi, genes, nucleotide sequences and dna-fragments encoding for said hydrophobins, and expression thereof
WO1999033982A3 (fr) Genes humains et produits d'expression genique i
IL123667A0 (en) Pneumococcal genes portions thereof expression products therefrom and uses of such genes portions and products
WO1999053061A3 (fr) Acides nucleiques associes a des tumeurs et leur emploi
IL135688A0 (en) Human checkpoint kinase, hcds1, compositions and methods
CA2167693A1 (fr) Proteine inhibitrice de melanomes
WO1998046771A3 (fr) Mocarhagine hautement purifiee, une protease du venin de cobra, polynucleotides codant cette protease et des proteases associees, et utilisations therapeutiques correspondantes
ZA982568B (en) The specificity of gene expression.
WO1998044104A3 (fr) Flip-gene et flip-proteine
AU6244296A (en) Novel beta-xylosidase, nucleotide sequence encoding it, and use thereof
EP1681350A3 (fr) Polypeptides et polynucleotides de Phorphorymonas gingivalis
CA2262465A1 (fr) La neuritine, un neurogene
AU1870597A (en) Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
WO2000043490A3 (fr) Gene de la rhamnosyl-tansferase et utilisations associees
MX9806041A (es) Proteina purificada sr-p70.
AU4390099A (en) Nucleotide sequences of the apple lrpkm1 gene, encoded amino acid sequence and uses thereof
EP0816504A3 (fr) Facteur d'activation des plaquettes acétylhydrolase, et gène codant celui-ci
CA2245584A1 (fr) Expression par recombinaison de proteines de couche superficielle
WO1999031230A3 (fr) Nouveau gene appele oligophrenine 1, produit d'expression, et applications diagnostiques et therapeutiques
HUP0001857A2 (hu) Bakteriális plazmidok
EP1826272A3 (fr) Gènes de Flavobactérium
CA2135200A1 (fr) Gene s d'un coronavirus canin et applications
AU6260796A (en) Isolated formylated bacterial peptides, nucleic acid molecul es and uses thereof
HUP9901346A2 (hu) Deltap62 polipeptid és variánsai, ezeket kódoló nukleinsav-szekvenciák és felhasználásuk

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2315268

Country of ref document: CA

Ref country code: CA

Ref document number: 2315268

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1998966703

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998966703

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09581422

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1998966703

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载